BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7866541)

  • 1. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
    Rivory LP; Robert J
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):133-41. PubMed ID: 7866541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HPLC assay for the lipophilic camptothecin analog AR-67 carboxylate and lactone in human whole blood.
    Tsakalozou E; Horn J; Leggas M
    Biomed Chromatogr; 2010 Oct; 24(10):1045-51. PubMed ID: 20853460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: application to cellular metabolism and accumulation studies.
    Hu ZP; Yang XX; Chen X; Chan E; Duan W; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):575-80. PubMed ID: 17270505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
    Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E; Posocco B; Mazzega E; Toffoli G
    PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Irinotecan and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometric.
    Zhang W; Dutschman GE; Li X; Ye M; Cheng YC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3038-44. PubMed ID: 19648066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detection.
    Hahn RZ; Arnhold PC; Andriguetti NB; Schneider A; Klück HM; Dos Reis SL; Bastiani MF; Kael I; da Silva ACC; Schwartsmann G; Antunes MV; Linden R
    J Pharm Biomed Anal; 2018 Feb; 150():51-58. PubMed ID: 29216585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-step pH-dependent liquid-liquid extraction combined with HPLC-fluorescence method for the determination of 10-hydroxycamptothecin in mouse liver tissue.
    Zheng J; Guo H; Guo N; Ma W; Jing L; Zhang R; Dai Z; Yan X; Wang Y; Wang Z
    Pharm Biol; 2012 Aug; 50(8):954-61. PubMed ID: 22486519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype.
    Corona G; Elia C; Casetta B; Toffoli G
    Ther Drug Monit; 2010 Oct; 32(5):638-46. PubMed ID: 20683392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of total and lactone form of a new camptothecin derivative gimatecan (ST1481) and its metabolite ST1698 in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Pace S; Capocasa F; Tallarico C; Frapolli R; Zucchetti M; Longo A
    J Pharm Biomed Anal; 2009 Oct; 50(3):507-14. PubMed ID: 19553057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) assay for simultaneous quantifications of CZ48, lactone-stabilized camptothecin, and camptothecin and their pharmacokinetic and biliary evaluations in rats.
    Kim YJ; Tu Y; Chow DS
    J Pharm Biomed Anal; 2018 Nov; 161():122-128. PubMed ID: 30149187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatography/electrospray ionization mass spectrometry (LC-MS/MS) assay for the determination of irinotecan (CPT-11) and its two major metabolites in human liver microsomal incubations and human plasma samples.
    D'Esposito F; Tattam BN; Ramzan I; Murray M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):522-30. PubMed ID: 18952506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice.
    Tagen M; Zhuang Y; Zhang F; Harstead KE; Shen J; Schaiquevich P; Fraga CH; Panetta JC; Waters CM; Stewart CF
    Drug Metab Lett; 2010 Dec; 4(4):195-201. PubMed ID: 20583968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases.
    Tang Y; Czuczman PR; Chung ST; Lewis AL
    J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles.
    Martins SM; Wendling T; Gonçalves VM; Sarmento B; Ferreira DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):100-7. PubMed ID: 22153332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
    Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
    J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.